Leptin, also known as OB protein or Adipokine, is an endogenous hormone predominantly produced by adipose tissue. It belongs to the cytokine family and is classified as a peptide hormone. Leptin plays a crucial role in regulating energy balance and body weight by signaling the brain to reduce appetite and increase energy expenditure. Researchers have extensively studied leptin's role in obesity, metabolic disorders, and its potential therapeutic applications. Leptin's primary physiological roles include the regulation of appetite and energy homeostasis. It acts as a satiety factor, communicating the body's energy status to the hypothalamus in the brain. Research areas include its involvement in obesity, metabolic syndrome, and its potential role in reproductive health and immune function. Leptin's mechanism of action involves binding to the leptin receptor (LEPR), a member of the class I cytokine receptor family, primarily located in the hypothalamus. This binding activates several signaling pathways, including the JAK-STAT pathway, which leads to the regulation of gene expression involved in appetite suppression and energy expenditure. The pharmacokinetic properties of leptin include a circulating half-life of approximately 30 minutes. It is primarily metabolized in the kidneys and liver. Leptin's bioavailability varies depending on the route of administration, with limited data on oral bioavailability due to degradation in the gastrointestinal tract. Clinically, leptin is used in the treatment of leptin deficiency and certain types of lipodystrophy. It is not widely approved for general obesity treatment. Regulatory standing varies by region, with specific approvals for rare metabolic disorders.